Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.78% | 135.80 | 0.0% | $896.66m | |
| AMGN | Amgen, Inc. | 0.02% | 253.05 | 1.5% | $851.98m | |
| GILD | Gilead Sciences, Inc. | -0.83% | 64.47 | 1.0% | $544.83m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.44% | 269.65 | 1.9% | $487.72m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.08% | 683.44 | 2.6% | $434.54m | |
| ILMN | Illumina, Inc. | 0.48% | 243.57 | 3.3% | $313.46m | |
| NVAX | Novavax, Inc. | 2.04% | 47.07 | 75.7% | $258.44m | |
| BIIB | Biogen, Inc. | 0.92% | 204.22 | 1.8% | $232.70m | |
| BNTX | BioNTech SE | 2.25% | 158.15 | 0.0% | $210.98m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 6.60% | 2.10 | 0.7% | $146.80m | |
| EXAS | EXACT Sciences Corp. | 2.95% | 49.86 | 17.7% | $128.20m | |
| TECH | Bio-Techne Corp. | 3.55% | 365.32 | 4.5% | $100.31m | |
| TXG | 10X Genomics, Inc. | 3.23% | 47.35 | 0.0% | $95.11m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.09% | 78.86 | 4.2% | $94.54m | |
| CRSP | CRISPR Therapeutics AG | 1.25% | 55.23 | 0.6% | $80.40m |
Company Profile
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.